Literature DB >> 17599410

TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells.

Gabi Theiner1, Susanne Rössner, Alexander Dalpke, Konrad Bode, Thomas Berger, André Gessner, Manfred B Lutz.   

Abstract

Toll-like receptors (TLR) are expressed on the surface or intracellularly by dendritic cells (DC) and recognize specifically different pathogen-associated molecular patterns (PAMPs). Increasing evidence suggests that TLR expressed by DC can cooperate to synergize their functions. Here, we describe the cooperation of TLR9 and TLR4 triggering of murine bone marrow derived DC by CpG oligonucleotides and LPS, respectively. The simultaneous DC stimulation of LPS and CpG showed additive effects on the production of IL-12 but not on other cytokines, such as TNF, IL-6 or IL-10. CpG pretreatment before LPS induced five times more IL-12p40 and IL-12p70 production by DC, whereas LPS pretreatment before CpG showed no effect. The optimal time interval between CpG and LPS treatment was 4h and the synergistic effects were dependent on myeloid differentiation factor 88 (MyD88) but independent from the DNA backbone and did not mediate by nucleosome remodeling. The stimulatory effect could be further enhanced by addition of IFN-gamma but not anti-CD40 antibodies. These data show, that TLR4 and TLR9 can cooperate to increase selectively IL-12 production by DC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599410     DOI: 10.1016/j.molimm.2007.02.021

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

1.  CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites.

Authors:  Y Yin; T Qin; X Wang; J Lin; Q Yu; Q Yang
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

2.  TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis.

Authors:  Sushmita Das; Mukta Rani; Vidyanand Rabidas; Krishna Pandey; Ganesh Chandra Sahoo; Pradeep Das
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Immune Response Modulation of Conjugated Agonists with Changing Linker Length.

Authors:  Keun Ah Ryu; Katarzyna Slowinska; Troy Moore; Aaron Esser-Kahn
Journal:  ACS Chem Biol       Date:  2016-10-25       Impact factor: 5.100

4.  Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells.

Authors:  J Wang; X Cao; J Zhao; H Zhao; J Wei; Q Li; X Qi; Z Yang; L Wang; H Zhang; L Bai; Z Wu; L Zhao; Z Hong; Z Yin
Journal:  Clin Exp Immunol       Date:  2017-01-05       Impact factor: 4.330

5.  Effects of CPG ODN on biological behavior of PANC-1 and expression of TLR9 in pancreatic cancer.

Authors:  Han-Qing Wu; Bo Wang; Shi-Kai Zhu; Yuan Tian; Jing-Hui Zhang; He-Shui Wu
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

6.  Intestinal epithelial cells modulate antigen-presenting cell responses to bacterial DNA.

Authors:  J L Campeau; S Y Salim; E J Albert; N Hotte; K L Madsen
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

7.  Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling.

Authors:  Katherine S Held; William G Glass; Yevgeniya I Orlovsky; Kimberly A Shamberger; Ted D Petley; Patrick J Branigan; Jill M Carton; Heena S Beck; Mark R Cunningham; Jacqueline M Benson; Thomas E Lane
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

8.  Enhanced antibody responses to a detoxified lipopolysaccharide-group B meningococcal outer membrane protein vaccine are due to synergistic engagement of Toll-like receptors.

Authors:  Wilbur H Chen; Subhendu Basu; Apurba K Bhattacharjee; Alan S Cross
Journal:  Innate Immun       Date:  2009-10-12       Impact factor: 2.680

9.  High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.

Authors:  Xinyuan Chen; Marco Pravetoni; Brijesh Bhayana; Paul R Pentel; Mei X Wu
Journal:  Vaccine       Date:  2012-10-30       Impact factor: 3.641

10.  TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients.

Authors:  Madhumita Jagannathan; Hatice Hasturk; Yanmei Liang; Hyunjin Shin; Jeremy T Hetzel; Alpdogan Kantarci; Daniel Rubin; Marie E McDonnell; Thomas E Van Dyke; Lisa M Ganley-Leal; Barbara S Nikolajczyk
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.